Exact Mass: 302.13520400000004
Exact Mass Matches: 302.13520400000004
Found 99 metabolites which its exact mass value is equals to given mass value 302.13520400000004,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Nicofetamide
C20H18N2O (302.14190579999996)
A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03A - Drugs for functional gastrointestinal disorders > A03AC - Synthetic antispasmodics, amides with tertiary amines
Phenylalanylhistidine
Phenylalanylhistidine is a dipeptide composed of phenylalanine and histidine. It is an incomplete breakdown product of protein digestion or protein catabolism. Dipeptides are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Some dipeptides are known to have physiological or cell-signalling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.
Histidylphenylalanine
Histidylphenylalanine is a dipeptide composed of histidine and phenylalanine. It is an incomplete breakdown product of protein digestion or protein catabolism. Dipeptides are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Some dipeptides are known to have physiological or cell-signalling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.
Garcinia lactone dibutyl ester
Garcinia lactone dibutyl ester is found in fruits. Garcinia lactone dibutyl ester is a constituent of the fruit of Garcinia atroviridis (gelugor). Constituent of the fruit of Garcinia atroviridis (gelugor). Garcinia lactone dibutyl ester is found in fruits.
4-[formyl(6-methoxyquinolin-8-yl)amino]pentanoic acid
3-[4-methyl-5-(3-methyl-5-oxo-4-vinyl-1,5-dihydro-pyrrol-2-ylidenemethyl)-2-oxo-2,3-dihydro-pyrrol-3-yl]-propionic acid|3-[4-Methyl-5-(3-methyl-5-oxo-4-vinyl-1,5-dihydro-pyrrol-2-ylidenmethyl)-2-oxo-2,3-dihydro-pyrrol-3-yl]-propionsaeure
(2alpha,3beta,5alpha)-2-(acetyloxy)-9-methoxy-5-(methoxycarbonyl)-2,3-dimethylheptano-5-lactone|rel-(2R,4R,5S)-2-(acetyloxy)tetrahydro-2-(1-methoxyethyl)-4,5-dimethyl-6-oxo-2H-pyran-2-carboxylic acid methyl ester
6-sec-butyl-3-(4-hydroxy-benzoyl)-5-methoxy-1H-pyrazin-2-one|Septorin
3-[4-methyl-5-(4-methyl-5-oxo-3-vinyl-1,5-dihydro-pyrrol-2-ylidenemethyl)-2-oxo-2,3-dihydro-pyrrol-3-yl]-propionic acid|3-[4-Methyl-5-(4-methyl-5-oxo-3-vinyl-1,5-dihydro-pyrrol-2-ylidenmethyl)-2-oxo-2,3-dihydro-pyrrol-3-yl]-propionsaeure
PRI_303.1340_15.8
CONFIDENCE Tentative identification: most likely structure (Level 3); INTERNAL_ID 1612
Phe-his
A dipeptide composed of L-phenylalanine and L-histidine joined by a peptide linkage.
(4R,4aS,7aR,12bS)-4a-hydroxy-9-methoxy-1,2,3,4,5,6,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one
4,4,5,5-TETRAMETHYL-2-[2-(2,2,2-TRIFLUORO-ETHOXY)-PHENYL]-[1,3,2]DIOXABOROLANE
C14H18BF3O3 (302.13010240000006)
3-o-acetyl-1,2:5,6-di-o-isopropylidene-alpha-d-glucofuranose
1-(4-AMINO-3-METHOXYPHENYL)-1-ETHANONE
C20H18N2O (302.14190579999996)
4,4,5,5-Tetramethyl-2-(3-methyl-5-(trifluoromethoxy)-phenyl)-1,3,2-dioxaborolane
C14H18BF3O3 (302.13010240000006)
4-(trifluoromethoxy)benzylboronic acid pinacol ester
C14H18BF3O3 (302.13010240000006)
2-(4-METHOXY-2-(TRIFLUOROMETHYL)PHENYL)-4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLANE
C14H18BF3O3 (302.13010240000006)
[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-benzofuran-6-yl] acetate
1H-Indole-1-carboxylic acid, 3-(1-cyano-1-methylethyl)-5-fluoro-, 1,1-dimethylethyl ester
1-decyl-3-methylimidazol-3-ium,bromide
C14H27BrN2 (302.13574819999997)
[R-(R*,S*)]-(-)-N-(1-PHENYLETHYL)-1-AZABICYCLO[2.2.2]OCTAN-3-AMINE DIHYDROCHLORIDE
C15H24Cl2N2 (302.13164439999997)
Safinamide
N - Nervous system > N04 - Anti-parkinson drugs > N04B - Dopaminergic agents > N04BD - Monoamine oxidase b inhibitors C471 - Enzyme Inhibitor > C667 - Monoamine Oxidase Inhibitor
8-benzyl-2,8-diazaspiro[4.5]decane
C15H24Cl2N2 (302.13164439999997)
3-BENZYL-N-HYDROXY-1-ISOPROPYL-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDINE-5-CARBOXIMIDAMIDE
4,4,5,5-TETRAMETHYL-2-[3-(2,2,2-TRIFLUORO-ETHOXY)-PHENYL]-[1,3,2]DIOXABOROLANE
C14H18BF3O3 (302.13010240000006)
N2-(1H-Indol-5-yl)-6-(pyridin-4-yl)pyrazine-2,3-diamine
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor
Propanamide, 2-[[[4-[(3-fluorophenyl)methoxy]phenyl]methyl]amino]-
methyl 5-[(4-tert-butylbenzoyl)amino]-2H-1,2,4-triazole-3-carboxylate
4-(4-Hydroxy-3-isopropylphenylthio)-2-isopropylphenol
N,N-Diphenylpyrazolo[1,5-A][1,3,5]triazine-2,4-diamine
2-[[2-amino-3-(1H-imidazol-5-yl)propanoyl]amino]-3-phenylpropanoic acid
4-[[(1S)-7-hydroxy-6-methoxy-1,2,3,4-tetrahydroisoquinolin-2-ium-1-yl]methyl]benzene-1,2-diol
(2R)-2-[[4-[(3-fluorophenyl)methoxy]phenyl]methylamino]propanamide
N-[2-methoxy-4-[(2-methyl-1-oxopropyl)amino]phenyl]-2-furancarboxamide
(S,S,S)-nicotianamine monoanion
C12H20N3O6- (302.13520400000004)
The tricarboxylic acid monoanion that is the conjugate base of (S,S,S)-nicotianamine, resulting from deprotonation of the central carboxy group and zwitterion formation of the other two. One of two major microspecies at physiological pH.
2-[[2-(3-Methyl-1-oxo-2-isoquinolinyl)-1-oxoethyl]amino]acetic acid ethyl ester
(4E)-4-(dimethylaminomethylidene)-2-(4-nitrophenyl)-5-propylpyrazol-3-one
N-(7-methyl-2,5-dioxo-4,4a,6,10b-tetrahydro-3H-pyrano[3,2-c]quinolin-3-yl)propanamide
3-hex-1-ynyl-5H-indazolo[2,3-a][3,1]benzoxazine
C20H18N2O (302.14190579999996)
5-(tert-butyl)-2-methyl-N-(4-nitrophenyl)-3-furamide
4-methoxy-2-[2-[5-methoxy-2-(oxidoamino)phenyl]ethyl]-N-oxidoaniline
3,4-Diethynyl-1,1-dimethyl-2,5-bis(trimethylsilyl)-1-silacyclopenta-2,5-diene
N-(1,2-Diphenylethyl)nicotinamide
C20H18N2O (302.14190579999996)
A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03A - Drugs for functional gastrointestinal disorders > A03AC - Synthetic antispasmodics, amides with tertiary amines
Phe-His zwitterion
A dipeptide zwitterion obtained by transfer of a proton from the carboxy to the amino terminus of Phe-His. Major species at pH 7.3.
(1s,2r,4r,6s,7s,9s,10r,11r)-2,9-dimethoxy-6,11-dimethyl-5,8,12-trioxatetracyclo[7.3.1.0²,⁷.0⁷,¹¹]tridecane-4,10-diol
5,6,7-trihydroxy-7-(6-oxo-2,3-dihydropyran-2-yl)heptan-3-yl acetate
(1as,3r,4r,4ar,7s,8as)-7-chloro-3-hydroxy-3,4a,8,8-tetramethyl-hexahydronaphtho[1,8a-b]oxirene-4-carboxylic acid
methyl (2s,4s,5r)-5-(acetyloxy)-2-[(1r)-1-methoxyethyl]-4,5-dimethyl-6-oxooxane-2-carboxylate
7-[(4,5-dihydroxyhex-2-enoyl)oxy]-4-hydroxyoct-2-enoic acid
methyl 5-(acetyloxy)-2-(1-methoxyethyl)-4,5-dimethyl-6-oxooxane-2-carboxylate
4-(3,3-dimethyloxiran-2-yl)-2-methylindolo[2,3-a]quinolizine
C20H18N2O (302.14190579999996)
2,4-dihydroxy-6,8-dioxabicyclo[3.2.1]octan-3-yl (7r)-7-hydroxyoct-2-enoate
4-[(2r)-3,3-dimethyloxiran-2-yl]-2-methylindolo[2,3-a]quinolizine
C20H18N2O (302.14190579999996)